297
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Effect of Prolonged Oral Acyclovir Treatment in Acute Retinal Necrosis

, MD, , MD, PhD, , MD, PhD & , MD
Pages 288-292 | Received 02 Jan 2012, Accepted 24 Apr 2012, Published online: 23 May 2012

REFERENCES

  • Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114(4):756–762.
  • Branisteanu D, Robu M, Antohi I, et al. [Acute retinal necrosis syndrome]. Oftalmologia. 2007;51(4):57–64.
  • Chang S, Young LH. Acute retinal necrosis: an overview. Int Ophthalmol Clin. 2007;47(2):145–154.
  • Hillenkamp J, Nolle B, Rautenberg P, et al. [Acute retinal necrosis: clinical features and therapy options]. Ophthalmologe. 2009;106(12):1058–1064.
  • Culbertson WW, Blumenkranz MS, Pepose JS, et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology. 1986;93(5):559–569.
  • Matsuo T, Nakayama T, Koyama T, et al. Cytological and immunological study of the aqueous humor in acute retinal necrosis syndrome. Ophthalmologica. 1987;195(1):38–44.
  • Lewis ML, Culbertson WW, Post JD, et al. Herpes simplex virus type 1: a cause of the acute retinal necrosis syndrome. Ophthalmology. 1989;96(6):875–878.
  • Kijlstra A, van den Horn GJ, Luyendijk L, et al. Laboratory tests in uveitis: new developments in the analysis of local antibody production. Doc Ophthalmol. 1990;75(3-4):225–231.
  • Nishi M, Hanashiro R, Mori S, et al. Polymerase chain reaction for the detection of the varicella-zoster genome in ocular samples from patients with acute retinal necrosis. Am J Ophthalmol. 1992;114(5):603–609.
  • de Boer JH, Luyendijk L, Rothova A, et al. Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol. 1994;117(2):201–210.
  • Sims JL, Yeoh J, Stawell RJ. Acute retinal necrosis: a case series with clinical features and treatment outcomes. Clin Exp Ophthalmol. 2009;37(5):473–477.
  • Palay DA, Sternberg P Jr., Davis J, et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol. 1991;112(3):250–255.
  • Tibbetts MD, Shah CP, Young LH, et al. Treatment of acute retinal necrosis. Ophthalmology. 2010;117(4):818–824.
  • Schulze-Bonsel K, Feltgen N, Burau H, et al. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240.
  • Halford WP, Gebhardt BM, Carr DJ. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol. 1996;157(8):3542–3549.
  • Shimeld C, Whiteland JL, Nicholls SM, et al. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol. 1995;61(1):7–16.
  • Kim SJ, Lo WR. Acute retinal necrosis. Ophthalmology. 2008;115(6):1104–1105; author reply 1105–1106.
  • Tran TH, Stanescu D, Caspers-Velu L, et al. Clinical characteristics of acute HSV-2 retinal necrosis. Am J Ophthalmol. 2004;137(5):872–879.
  • Okunuki Y, Usui Y, Kezuka T, et al. Four cases of bilateral acute retinal necrosis with a long interval after the initial onset. Br J Ophthalmol. 2011;95(9):1251–1254.
  • Divito S, Cherpes TL, Hendricks RL. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res. 2006;36(1-3):119–126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.